Delivery Order SPE2DB20D3103-SPE2DB23FP3U0
Award Date 8/15/23
Potential Completion Date 9/6/23
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $10,152 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. The place of performance is Conshohocken, Pennsylvania. The contract period runs from July 25, 2023 through August 15, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes valued at $5,578.50 with a firm fixed price contract type. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside competitive award, with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,157.00 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of October 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 17, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 3, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,757.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of November 10, 2025. This non-set-aside contract was competitively awarded on October 20, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.50 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zoladex 10.8 mg implant syringes, with completion scheduled for October 14, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a $1,692 delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania under a firm fixed price contract running from September 27 to October 19, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $1,985.82 delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by September 3, 2025, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction within AmerisourceBergen's broader federal pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP3U0Delivery Order
The Defense Logistics Agency awarded a $25,379 delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. As the prime contractor, Amerisourcebergen will provide the specified pharmaceutical products for use by the Department of Defense from its facility in Conshohocken, Pennsylvania. The firm fixed price contract runs from August 15, 2023 to September 6, 2023 and was issued under an existing DLA pharmaceutical supply vehicle. No subcontractors or set aside designations were identified. The award supports DLA's mission to provide logistics support for all military services and combatant commands.
Generated 12/22/23, 5:23 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.4k | 8/15/23 |